From Neoantigen Prediction to Clinical Response: Following the Journey of a Personalized Cancer Vaccine
10:00 am - Thursday 3rd December 2026
- Following the journey of a personalized cancer vaccine from neoantigen identification and AI-driven selection through vaccine design, manufacturing, and clinical administration
- Presenting translational insights from our clinical program by integrating immune monitoring, ctDNA dynamics, radiological assessment, and serial tumor biopsies to illustrate how different biomarkers capture vaccine activity
- Discussing how combining these complementary data provides a more comprehensive understanding of treatment response and clinical benefit, highlighting current challenges and future opportunities in personalized cancer vaccination
